The functional assessment of cancer therapy scale: Development and validation of the general measure

Journal of Clinical Oncology

Volumn 11, Issue 3, 1993, Pages 570-579

  Cella, David F ^a   Tulsky, David S ^a   Gray, George ^a   Sarafian, Bernie ^a   Linn, Elizabeth ^a   Bonomi, Amy ^a   Silberman, Margaret ^a   Yellen, Suzanne B ^a   Winicour, Patsy ^a   Brannon, Judy ^a   Eckberg, Karen ^a   Lloyd, Stephen ^a   Purl, Sandy ^a   Blendowski, Carol ^a   Goodman, Michelle ^a   Barnicle, Madeline ^a   Stewart, Irene ^a   McHale, Marnie ^a   Bonomi, Philip ^a   Kaplan, Edward ^a   Taylor IV, Samuel ^a   Thomas Jr , Charles R ^a   Harris, Jules ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; COLORECTAL CANCER; DOCTOR PATIENT RELATION; EMOTION; FACTORIAL ANALYSIS; FUNCTIONAL ASSESSMENT; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL STATUS;

ADULT; AGED; EVALUATION STUDIES; FACTOR ANALYSIS, STATISTICAL; HUMAN; INTERVIEWS; MIDDLE AGE; NEOPLASMS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027407786     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1993.11.3.570     Document Type: Article

References (46)

1. Aaronson NK, Beckman J: The Quality of Life of Cancer Patients. Monograph Series of the European Organization for Research on Treatment of Cancer (EORTC), vol 17. New York, NY, Raven, 1987
2. Barofsky I, Sugarbaker PH: Cancer, in Spilker B (ed): Qual-ity of Life Assessments in Clinical Trials. New York, NY, Raven. 1990, pp 419-439
3. Osoba D (ed): Effect of Cancer on Quality of Life, Boca Raton. FL, CRC, 1991
4. Tchekmedyian NS, Cella DF (eds): Quality of Life in Current Oncology Practice and Research. Williston Park, NY, Dominus Publishing, 1991
5. US Department of Health and Human Services, Public Health Service. National Institutes of Health: Quality of Life Assessment in Cancer Clinical Trials: Report of the Workshop on Quality of Life Research in Cancer Clinical Trials, Bethesda, MD, Division of Cancer Prevention and Control, National Cancer Institute. 1990
6. Moinpour CM, Feigl P, Metch B, et al: Quality of life end points in cancer clinical trials: Review and recommendations. J Natl Cancer Inst 81:485-495, 1989
7. Cella DF, Tulsky DS: Measuring quality of life today: Methodological aspects. Oncology 4:29-38, 1990
8. Gotay CC, Korn EL, McCabe MS, et al: Quality of life assessment in cancer treatment protocols: Research issues in protocol development. J Natl Cancer Inst 84:575-579, 1992
9. Donovan K, Sanson-Fisher RW, Redman S: Measuring quality of life in cancer patients. J Clin Oncol 7:959-968, 1989
10. Fayers PM, Jones DR: Measuring and analysing quality of life in cancer clinical trials: A review. Stat Med 2:429-446, 1983
11. Nayfield SG, Ganz PA, Moinpour CM, et al: Report from a National Cancer Institute (USA) Workshop on Quality of Life Assessment in Cancer Clinical Trials. Quality of Life Res 1:203-210, 1992
12. Cella DF, Cherin EA: Quality of life during and after cancer treatment. Compr Ther 14:69-75, 1988
13. Kaplan RM: Quality-of-life measurement, in Karoly P (ed): Measurement Strategies in Health Psychology. New York, NY, Wiley, 1985, pp 115-146
14. Schipper H, Levitt M: Measuring quality of life: Risks and benefits. Cancer Treat Rep 69:1115-1123, 1985
15. Johnson JR, Temple R: Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 69:1155-1157, 1985
16. Cella DF: Commentary on building quality of life assessment into cancer treatment studies. Oncology 6:30-32, 1992
17. Fetting JH: Evaluating quality and quantity of life in breast cancer adjuvant trials. J Clin Oncol 6:1795-1797, 1988
18. Skeel RT: Quality of life assessment in cancer clinical trialsIt's time to catch up. J Natl Cancer Inst 81:472-473, 1989
19. Schag CC, Heinrich RL: CARES. Cancer Rehabilitation Evaluation System. Los Angeles, CA, Cares Consultants, 1988
20. Ganz PA, Schag CAC, Lee JJ, et al: The CARES: A generic measure of health-related quality of life for patients with cancer. Quality of Life Res 1:19-29, 1992
21. Schipper H, Clinch J, McMurray A, et al: Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: Development and validation. J Clin Oncol 2:472-483, 1984
22. Aaronson NK, Ahmedzai S, Bullinger M, et al: The EORTC tore quality of life questionnaire: Interim results of an international field study, in Osoba D (ed): Effect of Cancer on Quality of Life. Boca Raton, FL, CRC, 1991, pp 185-203
23. Aaronson NK, Bullinger M, Ahmedzai S: A modular approach ID quality-of-life assessment in cancer clinical trials. Recent Results Cancer Res 111:231-249, 1988
24. Brook RH, Ware JE Jr, Davies-Avery A, et al: Overview of adult health status measures fielded in Rand's Health Insurance Study. Med Care 17:1-131, 1979 (suppl)
25. Stewart AL, Ware JE, Brook RH: Advances in the measure-ment of functional status: Construction of aggregate indexes. Med Care 19:473-488, 1981
26. Hays RD, Stewart AL: The structure of self-reported health in chronic disease patients. Psychol Assess 2:22-30, 1990
27. Cella DF, Jacobsen PB, Orav EJ, et al: A brief POMS measure of distress for cancer patients. J Chronic Dis 40:939-942, 1987
28. Spitzer WO, Dobson AJ, Hall J, et al: Measuring the quality of life of cancer patients: A concise QL-Index for use by physicians. J Chronic Dis 34:585-597, 1981
29. Cella DF, Lee-Riordan D, Silberman M, et al: Quality of life in advanced cancer: Three new disease-specific measures. Proc Am Soc Clin Oncol 8:315, 1989 (abstr 1225)
30. Cattell RB: The meaning and strategic use of factor analysis, in Cattell RB (ed): Handbook of Multivariate Experimental Psychology. Chicago, IL, Rand-McNally, 1966
31. Tabachnick BG, Fidell LS: Using Multivariate Statistics. New York, NY, Harper & Row, 1983
32. Zubrod CG, Schneiderman M, Frei E, et al: Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis 11:7-33, 1960
33. Taylor JA: A personality scale for manifest anxiety. J Abn Soc Psychol 48:285-290, 1953
34. Strahan R, Gerbasi KC: Short homogeneous versions of the Marlowe-Crowne Social Desirability Scale. J Clin Psychol 28:191-193, 1972
35. Wright BD, Masters GN: Rating Scale Analysis: Rasch Measurement. Chicago, IL, Mesa, 1982
36. Wright BD, Linacre JM: A User's Guide to the BIGSTEPS Rasch Model Computer Program, version 2.1. Chicago, IL, Mesa, 1991
37. Stenson HH: TESTAT: A Submodule of SYSTAT (version 2). Evanston, IL, SYSTAT, 1989
38. Cella DF, Orofiamma B, Holland JC, et al: Relationship of psychological distress, extent of disease, and performance status in patients with lung cancer. Cancer 60:239-245, 1987
39. Baum M, Priestman T, West RR, et al: A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast. Eur J Cancer 16:223-226, 1980 (suppl 1)
40. Padilla GV, Presant C, Grant MM, et al: Quality of life index for patients with cancer. Res Nurs Health 6:117-126, 1983
41. Priestman TJ, Baum M: Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet 1:899-901, 1976
42. Selby PJ, Chapman JAW, Etazadi-Amoli J, et al: The development of a method for assessing the quality of life of cancer patients. Br J Cancer 50:13-22, 1984
43. Levine MN, Guyatt GH, Gent M, et al: Quality of life in stage II breast cancer: An instrument for clinical trials. J Clin Oncol 6:1798-1810, 1988
44. Lansky SB, List MA, Lansky LL, et al: The measurement of performance in childhood cancer patients. Cancer 60:1651-1656, 1987
45. Aaronson NK, daSilva FC, Yoshida O, et al: Quality of life assessment in bladder cancer clinical trials: Conceptual, methodological and practical issues. Dev Bladder Cancer 149-170, 1986
46. Lansky SB, List MA, Ritter-Sterr C, et al: Performance parameters in head and neck patients. Proc Am Soc Clin Oncol 7:156, 1988 (abstr 603)